{'fraction_non_alphanumeric': 0.030634573304157548, 'fraction_numerical': 0.02261123267687819, 'mean_word_length': 5.017543859649122, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 1, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Speech Discrimination Scores Using the Latest Generation of Speech Processors

Abstract The Manchester Cochlear Implant Programme was established in 1988 and over 1000 patients have been implanted to date. Developments and improvements in cochlear implant technology over the past 21 years have resulted in new generations of implants and speech processors becoming available for use with patients. Since 2004, our patients have been asked to choose a device, based on their own preferences. This study looks at the speech discrimination scores of adults fitted with the latest generation of speech processors, including the Freedom (n = 40), the Harmony (n = 3) and the Opus 2 (n = 7). These scores are also compared to those of patients using earlier generations of speech processors, including the Esprit 3G (n = 89), the Auria (n = 9) and the Tempo+ (n = 38). Speech discrimination assessments (CUNY sentences, BKB sentences (in quiet and in noise) and AB words) were undertaken at the following intervals: 1 week, 3 months, 9 months and 21 months post switch-on. Patients were grouped according to their speech processor type and speech discrimination scores compared across the 6 groups. Our findings show that patients using the newer generation of speech processors tend to have higher speech discrimination scores than those using older generations of processor.